Amicus Therapeutics inc
Officers & Directors
1. John F. Crowley - Chairman and CEO
John Crowley is the Chairman and CEO of Amicus Therapeutics. He co-founded the company in 2002, driven by his desire to find a therapeutic cure for Pompe disease after two of his children were diagnosed with the rare genetic disorder. Prior to founding Amicus, he worked in the biotechnology and financial industries.
2. Bradley L. Campbell - President and COO
Bradley Campbell joined Amicus as President and COO in 2015. He brings over 15 years of experience in the pharmaceutical industry, having held senior leadership roles at Pfizer, Amylin Pharmaceuticals and ZS Pharma.
3. Daphne Quimi - Chief Financial Officer
Daphne Quimi joined Amicus as CFO in 2020. She has extensive experience in finance and accounting, having worked previously at Novo Nordisk, Merck and SmithKline Beecham.
4. Hung Do - Chief Science Officer
Hung Do is the Chief Science Officer at Amicus, responsible for leading the development of the company's scientific strategy. He has over 20 years of experience in drug discovery, having previously worked at Pfizer and Merck.
5. Jay Barth - Chief Medical Officer
Jay Barth is the Chief Medical Officer at Amicus, responsible for overseeing the clinical development of the company's pipeline. He has extensive experience in drug development, having worked previously at Janssen Pharmaceutical Companies of Johnson & Johnson and Merck.
6. William D. Baird III - Director
William Baird is a Director at Amicus Therapeutics. He has worked in the pharmaceutical industry for over 30 years, including at GlaxoSmithKline, Pfizer and Bristol-Myers Squibb.
Margaret G. McGlynn - Director
Margaret McGlynn is a Director at Amicus, bringing over 25 years of experience in the pharmaceutical industry. She has held senior leadership positions at Merck and the International AIDS Vaccine Initiative.
8. Michael Raab - Director
Michael Raab is a Director at Amicus and has more than 30 years of experience in the pharmaceutical industry. He has held leadership positions at Eli Lilly, Boehringer Ingelheim and Merck.
9. Seth H.Z. Fischer - Director
Seth Fischer is a Director at Amicus and brings over 30 years of experience in the pharmaceutical and healthcare industries. He has held leadership roles at Johnson & Johnson, BioMarin and Chugai Pharmaceutical.
Amicus Therapeutics inc currently has 511 employees.
|
